MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 183 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2016. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,000 | 0.0% | 61 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 61 | -29.9% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 87 | -8.4% | 0.00% | – |
| Q4 2020 | $2,000 | -99.2% | 95 | -99.4% | 0.00% | -100.0% |
| Q3 2020 | $265,000 | -26.8% | 15,564 | +0.3% | 0.01% | -27.3% |
| Q2 2020 | $362,000 | -43.0% | 15,511 | -76.8% | 0.01% | -26.7% |
| Q3 2019 | $635,000 | -22.7% | 66,951 | -3.4% | 0.02% | -21.1% |
| Q2 2019 | $821,000 | -29.4% | 69,305 | +4.5% | 0.02% | -32.1% |
| Q1 2019 | $1,163,000 | +138.8% | 66,302 | +136.6% | 0.03% | +133.3% |
| Q4 2018 | $487,000 | -21.5% | 28,023 | -20.0% | 0.01% | -20.0% |
| Q4 2016 | $620,000 | -11.9% | 35,034 | -4.0% | 0.02% | -6.2% |
| Q3 2016 | $704,000 | -1.0% | 36,501 | +0.0% | 0.02% | -11.1% |
| Q2 2016 | $711,000 | -1.4% | 36,485 | +6.5% | 0.02% | 0.0% |
| Q1 2016 | $721,000 | +613.9% | 34,244 | +597.4% | 0.02% | +800.0% |
| Q4 2015 | $101,000 | – | 4,910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |